If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced that on February 6, 2026, the Compensation Committee of Recursion's Board of ...

Is On Investors’ Radar Today Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt ...

It's a potential game-changing technology. The company just needs to prove to the world that it works well enough.

Last year's weakness is ultimately an improved entry opportunity for long-term-minded investors.

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER, BC, Jan. 29, 2026 /PRNewswire/ -- Equity-Insider.com News Commentary – The global AI medical imaging market exploded to a staggering $2.57 ...

A leaked bug report gives more info on Google's new OS. Aluminium OS will be the merging of Android and ChromeOS. The new OS should be released sometime this year. Google's plan to merge ChromeOS and ...

With over a decade of experience reporting on consumer technology, James covers mobile phones, apps, operating systems, wearables, AI, and more.

Multi-OS devices are finally becoming viable as Google, Microsoft, and Lenovo rethink how operating systems coexist across modern hardware. image: envato/melis82 The tech world has seen its share of ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...